Aprosulate sodium
Alternative Names: LW 10082; MW 2837Latest Information Update: 04 Jan 2019
At a glance
- Originator Luitpold Pharmaceuticals
- Class Anticoagulants; Antithrombotics
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Thromboembolism; Thrombosis
Most Recent Events
- 02 Jan 2019 Luitpold Pharmaceuticals is now called American Regent
- 10 Sep 1997 Phase-I clinical trials for Thromboembolism in Germany (SC)
- 10 Sep 1997 Phase-I clinical trials for Thrombosis in Germany (SC)